Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raymond H Mak, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
Available: 10/11/18, Expires: 10/10/20

My main research interests are to develop clinically-applicable biomarkers of both tumor response and radiation-induced toxicity after radiation therapy in patients with non-small cell lung cancer, using both novel imaging technologies and genetic analyses. Combining these genetic and imaging approaches will allow for an integrated “personalized” radiation therapy approach with a goal of widening the therapeutic window: both increasing the probability of tumor control while reducing the risk of radiation-induced injury.
Ongoing clinical-translational research work includes developing clinical databases with paired tissue and imaging repositories. Ongoing work includes analyzing clinical outcomes in non-small cell lung carcinoma (NSCLC) by tumor genotype and known mutations in tumor oncogenes such as EGFR and KRAS (Mak et al. Oncologist. 2011;16(6):886-95. PMCID:PMC3228219; Mak et al. Clinical Lung Cancer. 2015;16(1):24-32. PMCID: PMC4427190), and collaborations with Dr. Hugo Aerts to apply artificial intelligence and radiomics (quantitative analyses of clinically-acquired images of tumors) techniques to understand tumor phenotype in relation to tumor genotype, improve radiation therapy techniques, and outcomes in patients with non-small cell lung carcinoma (NSCLC). The critical component of this collaboration has been the development of a clinical database of over 1000 patients with NSCLC, paired tumor tissue repository, and a paired radiological imaging repository with manually segmented tumor volumes in over 600 patients, which we have assembled in the past 3 years.
Both scholarly projects and part-time projects available

Available: 05/03/19, Expires: 05/05/23

techniques to predict outcomes after radiation therapy for a variety of cancers. Recent work involves developing AI algorithms to replicate the skills of human experts in tumor targeting and RT planning.

Recent publications below:
https://jamanetwork.com/journals/jamaoncology/fullarticle/2730638

Available: 05/05/19, Expires: 05/31/21

Patient safety and quality improvement (QI) has become an increasingly important part of radiation oncology due to the increasingly complexity of radiation therapy delivery and technology. As a radiation oncology department delivering some of the newest, most complex, and technology-intensive treatment techniques, we have become increasingly concerned engineering work flows and processes that promote safe and high quality delivery of radiation therapy.

We have developed a customized safety reporting system that maps to our complex work flows and QI procedures, which allows frontline staff to report safety events and our QI team to perform quantitative analyses of safety events, and to conduct research into ways of improving radiation therapy safety. Projects are available on an ongoing basis, and can be tailored to varying student time commitments.

Available: 05/21/14, Expires: 06/30/20

Ongoing clinical research projects involve evaluating genetic predictors of tumor response to radiation (e.g. tumor mutations in EGFR and KRAS genes) and germline single nucleotide polymorphisms that predict risk of radiation toxicity. Additional projects incorporate functional imaging (e.g. MRI perfusion scans) to identify radiation-induced injury and tumor response. Specific sub-projects in the frame work of these studies would be identified in discussion with interested students and could entail either more short term or more long term studies.

Genetic and Clinical Predictors of Radiation Esophagitis in Lung Cancer Treatment
Summer, 06/17/13 - 08/16/13
Evaluation of CT Imaging Features of Non-Small Cell Lung Cancer During Chemoradiation
Full Time/Year Long, 08/01/14 - 08/15/15
Use of Frailty to Predict Survival in Elderly Patients with Early Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy
Full Time/Year Long, 09/01/15 - 09/30/16

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Atkins KM, Rawal B, Chaunzwa TL, Lamba N, Bitterman DS, Williams CL, Kozono DE, Baldini EH, Chen AB, Nguyen PL, D'Amico AV, Nohria A, Hoffmann U, Aerts HJWL, Mak RH. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer. J Am Coll Cardiol. 2019 Jun 18; 73(23):2976-2987. PMID: 31196455.
    Citations:    
  2. Schoenfeld JD, Nishino M, Severgnini M, Manos M, Mak RH, Hodi FS. Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features. J Immunother Cancer. 2019 Apr 24; 7(1):112. PMID: 31014385.
    Citations:    
  3. Xu Y, Hosny A, Zeleznik R, Parmar C, Coroller T, Franco I, Mak RH, Aerts HJWL. Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging. Clin Cancer Res. 2019 Jun 01; 25(11):3266-3275. PMID: 31010833.
    Citations:    
  4. Mak RH, Endres MG, Paik JH, Sergeev RA, Aerts H, Williams CL, Lakhani KR, Guinan EC. Use of Crowd Innovation to Develop an Artificial Intelligence-Based Solution for Radiation Therapy Targeting. JAMA Oncol. 2019 Apr 18. PMID: 30998808.
    Citations:    
  5. Soller L, Abrams EM, Carr S, Kapur S, Rex GA, Leo S, Lidman PG, Yeung J, Vander Leek TK, McHenry M, Wong T, Cook VE, Hildebrand KJ, Gerstner TV, Mak R, Lee NJ, Cameron SB, Chan ES. First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy. J Allergy Clin Immunol Pract. 2019 Apr 17. PMID: 31002957.
    Citations:    
  6. Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, Mak RH, Tamimi RM, Tempany CM, Swanton C, Hoffmann U, Schwartz LH, Gillies RJ, Huang RY, Aerts HJWL. Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019 Mar; 69(2):127-157. PMID: 30720861.
    Citations:    
  7. Zei PC, Mak R. Noninvasive Stereotactic Radioablation for Ventricular Tachycardia. Circulation. 2019 Jan 15; 139(3):322-324. PMID: 30586783.
    Citations:    Fields:    
  8. Hosny A, Parmar C, Coroller TP, Grossmann P, Zeleznik R, Kumar A, Bussink J, Gillies RJ, Mak RH, Aerts HJWL. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study. PLoS Med. 2018 11; 15(11):e1002711. PMID: 30500819.
    Citations:    Fields:    
  9. Dou TH, Coroller TP, van Griethuysen JJM, Mak RH, Aerts HJWL. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC. PLoS One. 2018; 13(11):e0206108. PMID: 30388114.
    Citations:    Fields:    
  10. Bitterman DS, Zei PC, Mak RH. Radiation Safety and Cardiovascular Implantable Electronic Devices. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):243-246. PMID: 30191855.
    Citations:    Fields:    Translation:Humans
  11. Hou Y, Hermann G, Lewis JH, Aerts HJ, Baldini EH, Chen AB, Colson YL, Hacker FL, Killoran JH, Kozono DE, Wagar M, Wee JO, Mak RH. Clinical Outcomes After Lung Stereotactic Body Radiation Therapy in Patients With or Without a Prior Lung Resection. Am J Clin Oncol. 2018 07; 41(7):695-701. PMID: 27819875.
    Citations:    Fields:    
  12. Markmiller S, Soltanieh S, Server KL, Mak R, Jin W, Fang MY, Luo EC, Krach F, Yang D, Sen A, Fulzele A, Wozniak JM, Gonzalez DJ, Kankel MW, Gao FB, Bennett EJ, Lécuyer E, Yeo GW. Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules. Cell. 2018 01 25; 172(3):590-604.e13. PMID: 29373831.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  13. Diao K, Chen YH, Catalano PJ, Lee S, Milani N, Killoran JH, Baldini EH, Chen AB, Kozono DE, Mak RH. Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques. Radiother Oncol. 2017 11; 125(2):301-309. PMID: 29102264.
    Citations:    Fields:    Translation:Humans
  14. Yip SSF, Parmar C, Kim J, Huynh E, Mak RH, Aerts HJWL. Impact of experimental design on PET radiomics in predicting somatic mutation status. Eur J Radiol. 2017 Dec; 97:8-15. PMID: 29153372.
    Citations: 1     Fields:    Translation:Humans
  15. Franco I, Chen YH, Chipidza F, Agrawal V, Romano J, Baldini E, Chen A, Colson Y, Hou Y, Kozono D, Wee J, Mak R. Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy. J Geriatr Oncol. 2018 03; 9(2):130-137. PMID: 28941581.
    Citations:    Fields:    
  16. Martínez P, Mak RH, Oxnard GR. Targeted Therapy as an Alternative to Whole-Brain Radiotherapy in EGFR-Mutant or ALK-Positive Non-Small-Cell Lung Cancer With Brain Metastases. JAMA Oncol. 2017 Sep 01; 3(9):1274-1275. PMID: 28520828.
    Citations: 1     Fields:    Translation:Humans
  17. Aizer AA, Mak R, Alexander BM. Prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer. Neuro Oncol. 2017 08 01; 19(8):1015-1016. PMID: 28854622.
    Citations:    Fields:    
  18. Rios Velazquez E, Parmar C, Liu Y, Coroller TP, Cruz G, Stringfield O, Ye Z, Makrigiorgos M, Fennessy F, Mak RH, Gillies R, Quackenbush J, Aerts HJWL. Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer. Cancer Res. 2017 07 15; 77(14):3922-3930. PMID: 28566328.
    Citations: 6     Fields:    Translation:Humans
  19. Agrawal V, Coroller TP, Hou Y, Lee SW, Romano JL, Baldini EH, Chen AB, Kozono D, Swanson SJ, Wee JO, Aerts HJWL, Mak RH. Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC. PLoS One. 2017; 12(4):e0174268. PMID: 28426673.
    Citations:    Fields:    Translation:Humans
  20. Wang M, Han J, Marcar L, Black J, Liu Q, Li X, Nagulapalli K, Sequist LV, Mak RH, Benes CH, Hong TS, Gurtner K, Krause M, Baumann M, Kang JX, Whetstine JR, Willers H. Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR Pathway. Cancer Res. 2017 04 15; 77(8):2018-2028. PMID: 28202526.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  21. Sundaramoorthy E, Leonard M, Mak R, Liao J, Fulzele A, Bennett EJ. ZNF598 and RACK1 Regulate Mammalian Ribosome-Associated Quality Control Function by Mediating Regulatory 40S Ribosomal Ubiquitylation. Mol Cell. 2017 Feb 16; 65(4):751-760.e4. PMID: 28132843.
    Citations: 12     Fields:    Translation:HumansCells
  22. Huynh E, Coroller TP, Narayan V, Agrawal V, Romano J, Franco I, Parmar C, Hou Y, Mak RH, Aerts HJ. Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT. PLoS One. 2017; 12(1):e0169172. PMID: 28046060.
    Citations: 10     Fields:    Translation:Humans
  23. Coroller TP, Agrawal V, Huynh E, Narayan V, Lee SW, Mak RH, Aerts HJWL. Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC. J Thorac Oncol. 2017 03; 12(3):467-476. PMID: 27903462.
    Citations: 7     Fields:    Translation:Humans
  24. Agrawal V, Coroller TP, Hou Y, Lee SW, Romano JL, Baldini EH, Chen AB, Jackman DM, Kozono D, Swanson SJ, Wee JO, Aerts HJ, Mak RH. Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC. Lung Cancer. 2016 12; 102:1-8. PMID: 27987576.
    Citations: 2     Fields:    Translation:Humans
  25. Hou Y, Lee S, Agrawal V, Romano J, Baldini EH, Chen AB, Kozono DE, Killoran JH, Wagar M, Hacker FL, Aerts HJ, Lewis JH, Mak RH. Inter-scan and inter-observer tumour volume delineation variability on cone beam computed tomography in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. J Med Imaging Radiat Oncol. 2017 Feb; 61(1):93-98. PMID: 27709803.
    Citations:    Fields:    Translation:Humans
  26. Yip SS, Kim J, Coroller TP, Parmar C, Velazquez ER, Huynh E, Mak RH, Aerts HJ. Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer. J Nucl Med. 2017 04; 58(4):569-576. PMID: 27688480.
    Citations: 11     Fields:    Translation:Humans
  27. Mak RH, Hunt D, Efstathiou JA, Heney NM, Jones CU, Lukka HR, Bahary JP, Patel M, Balogh A, Nabid A, Leibenhaut MH, Hamstra DA, Roof KS, Jeffrey Lee R, Gore EM, Sandler HM, Shipley WU. Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01. Urol Oncol. 2016 10; 34(10):430.e1-7. PMID: 27381895.
    Citations:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  28. Huynh E, Coroller TP, Narayan V, Agrawal V, Hou Y, Romano J, Franco I, Mak RH, Aerts HJ. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer. Radiother Oncol. 2016 08; 120(2):258-66. PMID: 27296412.
    Citations: 16     Fields:    Translation:Humans
  29. Huynh E, Coroller T, Narayan V, Agrawal V, Hou Y, Romano J, Franco I, Mak R, Aerts H. SU-F-R-53: CT-Based Radiomics Analysis of Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy. Med Phys. 2016 Jun; 43(6):3385. PMID: 28048830.
    Citations:    
  30. Yip S, Kim J, Coroller T, Rios Velazquez E, Parmar C, Mak R, Aerts H. MO-DE-207B-01: JACK FOWLER JUNIOR INVESTIGATOR COMPETITION WINNER: Between Somatic Mutations and PET-Based Radiomic Features in Non-Small Cell Lung Cancer. Med Phys. 2016 Jun; 43(6):3704. PMID: 28048737.
    Citations:    
  31. Coroller T, Yip S, Kim J, Lee S, Mak R, Aerts H. SU-D-207B-03: A PET-CT Radiomics Comparison to Predict Distant Metastasis in Lung Adenocarcinoma. Med Phys. 2016 Jun; 43(6):3349. PMID: 28047618.
    Citations:    
  32. Huynh E, Coroller T, Narayan V, Agrawal V, Romano J, Franco I, Hou Y, Mak R, Aerts H. SU-F-R-52: A Comparison of the Performance of Radiomic Features From Free Breathing and 4DCT Scans in Predicting Disease Recurrence in Lung Cancer SBRT Patients. Med Phys. 2016 Jun; 43(6):3385. PMID: 28046768.
    Citations:    
  33. Coroller T, Agrawal V, Narayan V, Lee S, Mak R, Aerts H. TU-D-207B-06: Pathological Response Prediction by Radiomic Data From Primary and Lymph Nodes in NSCLC. Med Phys. 2016 Jun; 43(6):3751. PMID: 28046592.
    Citations:    
  34. Coroller TP, Agrawal V, Narayan V, Hou Y, Grossmann P, Lee SW, Mak RH, Aerts HJ. Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol. 2016 06; 119(3):480-6. PMID: 27085484.
    Citations: 29     Fields:    Translation:Humans
  35. Agrawal V, Marcoux JP, Rabin MS, Vernovsky I, Wee JO, Mak RH. Case report of tracheobronchial squamous cell carcinoma treated with radiation therapy and concurrent chemotherapy. Adv Radiat Oncol. 2016 Apr-Jun; 1(2):127-131. PMID: 28740880.
    Citations:    
  36. Wu W, Parmar C, Grossmann P, Quackenbush J, Lambin P, Bussink J, Mak R, Aerts HJ. Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology. Front Oncol. 2016; 6:71. PMID: 27064691.
    Citations: 23     
  37. Li R, Hermann G, Baldini E, Chen A, Jackman D, Kozono D, Nguyen P, Nohria A, Powell G, Mak R. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer. Lung Cancer. 2016 06; 96:41-7. PMID: 27133748.
    Citations: 3     Fields:    Translation:Humans
  38. Hou Y, Aileen C, Kozono D, Killoran J, Wagar M, Lee S, Hacker F, Aerts H, Lewis J, Mak R. SU-E-J-266: Cone Beam Computed Tomography (CBCT) Inter-Scan and Inter-Observer Tumor Volume Variability Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Early Stage Non-Small Cell Lung Cancer (NSCLC). Med Phys. 2015 Jun; 42(6):3328. PMID: 26127657.
    Citations:    
  39. Coroller T, Grossmann P, Hou Y, Lee S, Mak R, Aerts H. SU-E-J-246: CT-Based Volumetric Features Are Associated with Somatic Mutations in Lung Cancer. Med Phys. 2015 Jun; 42(6):3322. PMID: 26127634.
    Citations:    
  40. Coroller TP, Grossmann P, Hou Y, Rios Velazquez E, Leijenaar RT, Hermann G, Lambin P, Haibe-Kains B, Mak RH, Aerts HJ. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. Radiother Oncol. 2015 Mar; 114(3):345-50. PMID: 25746350.
    Citations: 77     Fields:    Translation:Humans
  41. Baldini EH, Richards WG, Gill RR, Goodman BM, Winfrey OK, Eisen HM, Mak RH, Chen AB, Kozono DE, Bueno R, Sugarbaker DJ. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2015 May; 149(5):1374-81. PMID: 25772281.
    Citations: 8     Fields:    Translation:Humans
  42. Hurwitz M, Williams CL, Mishra P, Rottmann J, Dhou S, Wagar M, Mannarino EG, Mak RH, Lewis JH. Generation of fluoroscopic 3D images with a respiratory motion model based on an external surrogate signal. Phys Med Biol. 2015 Jan 21; 60(2):521-35. PMID: 25548999.
    Citations: 1     Fields:    Translation:Humans
  43. Herter-Sprie GS, Korideck H, Christensen CL, Herter JM, Rhee K, Berbeco RI, Bennett DG, Akbay EA, Kozono D, Mak RH, Mike Makrigiorgos G, Kimmelman AC, Wong KK. Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models. Nat Commun. 2014 Dec 18; 5:5870. PMID: 25519892.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  44. Mak RH, Hunt D, Shipley WU, Efstathiou JA, Tester WJ, Hagan MP, Kaufman DS, Heney NM, Zietman AL. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol. 2014 Dec 01; 32(34):3801-9. PMID: 25366678.
    Citations: 37     Fields:    Translation:Humans
  45. Mak RH, Hermann G, Lewis JH, Aerts HJ, Baldini EH, Chen AB, Colson YL, Hacker FH, Kozono D, Wee JO, Chen YH, Catalano PJ, Wong KK, Sher DJ. Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Clin Lung Cancer. 2015 Jan; 16(1):24-32. PMID: 25450872.
    Citations: 11     Fields:    Translation:Humans
  46. Mishra P, Li R, Mak RH, Rottmann J, Bryant JH, Williams CL, Berbeco RI, Lewis JH. An initial study on the estimation of time-varying volumetric treatment images and 3D tumor localization from single MV cine EPID images. Med Phys. 2014 Aug; 41(8):081713. PMID: 25086523.
    Citations: 5     Fields:    Translation:Humans
  47. Parmar C, Rios Velazquez E, Leijenaar R, Jermoumi M, Carvalho S, Mak RH, Mitra S, Shankar BU, Kikinis R, Haibe-Kains B, Lambin P, Aerts HJ. Robust Radiomics feature quantification using semiautomatic volumetric segmentation. PLoS One. 2014; 9(7):e102107. PMID: 25025374.
    Citations: 64     Fields:    Translation:Humans
  48. Gray PJ, Mak RH, Yeap BY, Cryer SK, Pinnell NE, Christianson LW, Sher DJ, Arvold ND, Baldini EH, Chen AB, Kozono DE, Swanson SJ, Jackman DM, Alexander BM. Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival. Lung Cancer. 2014 Aug; 85(2):239-44. PMID: 24974152.
    Citations: 15     Fields:    Translation:Humans
  49. Coroller T, Grossman P, Rios E, Mak R, Aerts H. WE-E-17A-04: CT Based Radiomics Data Predicts for Nodal Involvement and Overall Survival in NSCLC. Med Phys. 2014 Jun; 41(6):508. PMID: 28037615.
    Citations:    
  50. Parikh RB, Cronin AM, Kozono DE, Oxnard GR, Mak RH, Jackman DM, Lo PC, Baldini EH, Johnson BE, Chen AB. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):880-7. PMID: 24867533.
    Citations: 14     Fields:    Translation:Humans
  51. Coroller TP, Mak RH, Lewis JH, Baldini EH, Chen AB, Colson YL, Hacker FL, Hermann G, Kozono D, Mannarino E, Molodowitch C, Wee JO, Sher DJ, Killoran JH. Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry. PLoS One. 2014; 9(4):e94859. PMID: 24728448.
    Citations: 7     Fields:    Translation:Humans
  52. Velazquez ER, Parmar C, Jermoumi M, Mak RH, van Baardwijk A, Fennessy FM, Lewis JH, De Ruysscher D, Kikinis R, Lambin P, Aerts HJ. Volumetric CT-based segmentation of NSCLC using 3D-Slicer. Sci Rep. 2013 Dec 18; 3:3529. PMID: 24346241.
    Citations: 24     Fields:    Translation:Humans
  53. Williams CL, Mishra P, Seco J, St James S, Mak RH, Berbeco RI, Lewis JH. A mass-conserving 4D XCAT phantom for dose calculation and accumulation. Med Phys. 2013 Jul; 40(7):071728. PMID: 23822432.
    Citations: 4     Fields:    Translation:Humans
  54. Williams C, Mishra P, Seco J, St James S, Wagar M, Mak R, Berbeco R, Lewis J. SU-C-141-07: A Mass-Conserving 4D XCAT Phantom Enabling Normal Tissue Deformable Dose Accumulation. Med Phys. 2013 Jun; 40(6Part2):93. PMID: 28518311.
    Citations:    
  55. Coroller T, Lewis J, Mak R, Chen A, Hacker F, Kozono D, Mannarino E, Molodowitch C, Killoran J. SU-E-T-694: Correlation Between Geometric Information and Dose Fractionation in Lung SBRT Treatment Plans. Med Phys. 2013 Jun; 40(6Part21):365-366. PMID: 28519454.
    Citations:    
  56. Williams C, Seco J, Mishra P, St James S, Mak R, Berbeco R, Lewis J. SU-E-J-29: Assessing the Dosimetric Effects of Tumor Tracking During Irregular Respiration Using a Mass-Conserving XCAT Phantom. Med Phys. 2013 Jun; 40(6Part7):156. PMID: 28519880.
    Citations:    
  57. Lewis J, Mamata H, Tokuda J, Mishra P, Hermann G, Hatabu H, Nishino M, Mak R. TH-C-141-08: A Feasibility Study of the Utility of Dynamic Contrast-Enhanced MRI for Treatment Planning and Monitoring Treatment Response in Lung Stereotactic Body Radiation Therapy. Med Phys. 2013 Jun; 40(6Part33):540. PMID: 28519198.
    Citations:    
  58. Mishra P, Li R, James SS, Mak RH, Williams CL, Yue Y, Berbeco RI, Lewis JH. Evaluation of 3D fluoroscopic image generation from a single planar treatment image on patient data with a modified XCAT phantom. Phys Med Biol. 2013 Feb 21; 58(4):841-58. PMID: 23337614.
    Citations: 4     Fields:    Translation:Humans
  59. Mishra P, Li R, St James S, Yue Y, Mak R, Berbeco R, Lewis J. SU-E-J-126: Generation of Fluoroscopic 3D Images Using Single X-Ray Projections on Realistic Modified XCAT Phantom Data. Med Phys. 2012 Jun; 39(6Part8):3681. PMID: 28518907.
    Citations:    Fields:    
  60. Lewis J, Mak R, Molodowitch C, Mannarino E, Baldini E, Chen A, Kozono D, Sher D, Hacker F, Killoran J. TU-E-BRB-02: A Decision Support Tool for SBRT Planning Using a Searchable DVH Database. Med Phys. 2012 Jun; 39(6Part24):3908. PMID: 28518686.
    Citations:    Fields:    
  61. Mak RH, Hunt D, Shipley WU, Efstathiou JA, Tester WJ, Hagan MP, Kaufman DS, Heney NM, Zietman AL. Long-term outcomes in patients with muscle-invasive bladder cancer after bladder-preserving combined-modality therapy: A pooled analysis of RTOG 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol. 2012 Feb 10; 30(5_suppl):264. PMID: 28143313.
    Citations:    
  62. Mak RH, Alexander BM, Asomaning K, Heist RS, Liu CY, Su L, Zhai R, Ancukiewicz M, Napolitano B, Niemierko A, Willers H, Choi NC, Christiani DC. A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy. Cancer. 2012 Jul 15; 118(14):3654-65. PMID: 22144047.
    Citations: 9     Fields:    Translation:Humans
  63. Alexander BM, Wang XZ, Niemierko A, Weaver DT, Mak RH, Roof KS, Fidias P, Wain J, Choi NC. DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):164-71. PMID: 22000749.
    Citations: 18     Fields:    Translation:HumansCells
  64. Mak RH, Doran E, Muzikansky A, Kang J, Neal JW, Baldini EH, Choi NC, Willers H, Jackman DM, Sequist LV. Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC. Oncologist. 2011; 16(6):886-95. PMID: 21632451.
    Citations: 17     Fields:    Translation:Humans
  65. Mak RH, Digumarthy SR, Muzikansky A, Engelman JA, Shepard JA, Choi NC, Sequist LV. Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer. Oncologist. 2011; 16(3):319-26. PMID: 21339258.
    Citations: 24     Fields:    Translation:Humans
  66. Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, McConkey ME, Habib N, Yosef N, Chang CY, Shay T, Frampton GM, Drake AC, Leskov I, Nilsson B, Preffer F, Dombkowski D, Evans JW, Liefeld T, Smutko JS, Chen J, Friedman N, Young RA, Golub TR, Regev A, Ebert BL. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell. 2011 Jan 21; 144(2):296-309. PMID: 21241896.
    Citations: 285     Fields:    Translation:Humans
  67. Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE. Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a Surveillance, Epidemiology, and End Results Patterns-of-Care Study. Int J Radiat Oncol Biol Phys. 2011 Jul 15; 80(4):978-84. PMID: 20961695.
    Citations: 7     Fields:    Translation:Humans
  68. Mak RH, Halasz LM, Tanaka CK, Ancukiewicz M, Schultz DJ, Russell AH, Viswanathan AN. Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva. Gynecol Oncol. 2011 Jan; 120(1):101-7. PMID: 20950845.
    Citations: 6     Fields:    Translation:Humans
  69. Mak KS, Lee LK, Mak RH, Wang S, Pile-Spellman J, Abrahm JL, Prigerson HG, Balboni TA. Incidence and treatment patterns in hospitalizations for malignant spinal cord compression in the United States, 1998-2006. Int J Radiat Oncol Biol Phys. 2011 Jul 01; 80(3):824-31. PMID: 20630663.
    Citations: 11     Fields:    Translation:Humans
  70. Bradner JE, Mak R, Tanguturi SK, Mazitschek R, Haggarty SJ, Ross K, Chang CY, Bosco J, West N, Morse E, Lin K, Shen JP, Kwiatkowski NP, Gheldof N, Dekker J, DeAngelo DJ, Carr SA, Schreiber SL, Golub TR, Ebert BL. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc Natl Acad Sci U S A. 2010 Jul 13; 107(28):12617-22. PMID: 20616024.
    Citations: 57     Fields:    Translation:Humans
  71. Mak RH, Mamon HJ, Ryan DP, Miyamoto DT, Ancukiewicz M, Kobayashi WK, Willett CG, Choi NC, Blaszkowsky LS, Hong TS. Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older. Dis Esophagus. 2010 May; 23(4):316-23. PMID: 19788436.
    Citations: 11     Fields:    Translation:Humans
  72. Mak RH, Zietman AL, Heney NM, Kaufman DS, Shipley WU. Bladder preservation: optimizing radiotherapy and integrated treatment strategies. BJU Int. 2008 Nov; 102(9 Pt B):1345-53. PMID: 19035903.
    Citations: 9     Fields:    Translation:Humans
  73. Haining WN, Ebert BL, Subrmanian A, Wherry EJ, Eichbaum Q, Evans JW, Mak R, Rivoli S, Pretz J, Angelosanto J, Smutko JS, Walker BD, Kaech SM, Ahmed R, Nadler LM, Golub TR. Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cells. J Immunol. 2008 Aug 01; 181(3):1859-68. PMID: 18641323.
    Citations: 36     Fields:    Translation:HumansAnimalsCells
  74. Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J, Pretz J, Schlanger R, Wang JY, Mak RH, Dombkowski DM, Preffer FI, Scadden DT, Golub TR. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell. 2008 Jun; 14(6):843-53. PMID: 18539114.
    Citations: 127     Fields:    Translation:HumansAnimalsCells
  75. Ebert BL, Galili N, Tamayo P, Bosco J, Mak R, Pretz J, Tanguturi S, Ladd-Acosta C, Stone R, Golub TR, Raza A. An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome. PLoS Med. 2008 Feb; 5(2):e35. PMID: 18271621.
    Citations: 47     Fields:    Translation:HumansCells
  76. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature. 2005 Jun 09; 435(7043):834-8. PMID: 15944708.
    Citations: 3008     Fields:    Translation:HumansAnimals
  77. Ebert BL, Lee MM, Pretz JL, Subramanian A, Mak R, Golub TR, Sieff CA. An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray. Blood. 2005 Jun 15; 105(12):4620-6. PMID: 15755903.
    Citations: 33     Fields:    Translation:HumansCells
  78. Leung AY, Mak R, Lie AK, Yuen KY, Cheng VC, Liang R, Kwong YL. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant. 2002 Mar; 29(6):509-13. PMID: 11960271.
    Citations: 17     Fields:    Translation:HumansCells
  79. Cromheecke ME, Levi M, Colly LP, de Mol BJ, Prins MH, Hutten BA, Mak R, Keyzers KC, Büller HR. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet. 2000 Jul 08; 356(9224):97-102. PMID: 10963245.
    Citations:    
  80. Alfrey EJ, Salvatierra O, Tanney DC, Mak R, Scandling JD, Dafoe DC, Hammer GB, Orlandi PD, Page L, Conley SB. Bladder augmentation can be problematic with renal failure and transplantation. Pediatr Nephrol. 1997 Dec; 11(6):672-5. PMID: 9438639.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mak's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (310)
Explore
_
Co-Authors (90)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.